We found that CAFs from malignant fluids of ovarian cancer receive a specific signaling pattern from cancer cells, mainly composed of ligands associated with neovascularization processes, differentiation pathway, EGFR tyrosine kinase inhibitor resistance, and IL-6/JAK/STAT3 signaling (Fig. 4D). The gene discussed is STAT3; the disease is ovarian cancer.